Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Hep C Tests Down-Classified By FDA
The IVDs, now moderate-risk class II, had been high-risk class III
Nov 19 2021
•
By
Shawn M. Schmitt
More from In Vitro Diagnostics
More from Diagnostics